Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroblastoma × talazoparib × Clear all

Sponsor

Conditions

Breast Neoplasms 12 Triple Negative Breast Neoplasms 5 Advanced Solid Tumors 4 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Pancreatic Neoplasms 2 Neoplasms 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 mCRPC 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Hereditary Sensory and Autonomic Neuropathies 1 Fanconi Anemia, Complementation Group D1 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Adenocarcinoma 1 Advanced Solid Tumor 1 Advanced Ovarian Cancer 1 ATM Gene Mutation 1

Interventions

Cyclophosphamide 20 Isotretinoin 14 Topotecan 12 Irinotecan 12 Etoposide 12 Temozolomide 10 Doxorubicin 10 dinutuximab 9 Magnetic Resonance Spectroscopy 9 sargramostim 8 Vincristine 8 Melphalan 8 Filgrastim 7 Cisplatin 7 Granulocyte-Macrophage Colony-Stimulating Factor 6 Granulocyte Colony-Stimulating Factor 6 3-Iodobenzylguanidine 6 Specimen Handling 5 Carboplatin 5 fludarabine 4 etoposide phosphate 4 aldesleukin 4 X-Rays 4 Stem Cell Transplantation 4 Radiotherapy 4 Phantoms, Imaging 4 Mesna 4 Colony-Stimulating Factors 4 Busulfan 4 Biopsy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡